Shift Health co-hosted a Product Development Boot Camp with the Global HIV Vaccine Enterprise. The Boot Camp afforded workshop participants an opportunity to discuss best practices, to learn from the experience of other experts and to create an enduring resource and toolkit that will serve the HIV vaccine field and beyond.
Product development refers to the multifaceted, long-term, highly regulated process that brings promising new drugs, vaccines and medical devices to the populations who most need them. In fields such as HIV vaccine development, where the absence of commercial incentives can make it difficult for companies to lead this process on their own, inventors need to work in partnership with diverse stakeholders and funders to maximize the social and economic impact of their research.
Anne Mullin, PhD, Engagement Leader, Director, Team Performance and Development at Shift Health, outlined the elements of planning for trial success:
- Build contingency plans around potential scenarios
- Define proactive and reactive responses in a prescriptive and unambiguous manner
- Ensure that contingency plans set the stage for future product access.